This topic contains a solution. Click here to go to the answer

Author Question: Who led a revolt against the Seleucid monarchy in Judea in the 160s B.C.E.? a. Isaiah b. ... (Read 75 times)

Shelles

  • Hero Member
  • *****
  • Posts: 582

Question 1

During the eleventh century B.C., the twelve Hebrew tribes united under the leadership of
 
  a. Saul.
  b. David.
  c. Solomon.
  d. Abraham.
  e. Moses.

Question 2

Who led a revolt against the Seleucid monarchy in Judea in the 160s B.C.E.?
 
  a. Isaiah
  b. Antiochus IV
  c. Judas Iscariot
  d. Jesus of Nazareth
  e. Judas Maccabaeus



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tuate

  • Sr. Member
  • ****
  • Posts: 332


Shelles

  • Member
  • Posts: 582
Reply 2 on: Sep 12, 2019
Great answer, keep it coming :)


milbourne11

  • Member
  • Posts: 322
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library